Clinical Trial Update: A Study of Molecular Residual, Dynamic Monitoring and Recurrence of Stage III Driver Mutated NSCLC

View source ↗

Summary

This clinical study investigates molecular residual disease, dynamic monitoring, and recurrence in Stage III driver-mutated non-small cell lung cancer; the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Shanghai Chest Hospital | Conditions: Non Small Cell Lung Cancer | Status: RECRUITING